Status:
COMPLETED
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Advanced Cutaneous Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to examine the safety of Ipilimumab and patterns of use in the treatment of unresectable or metastatic melanoma in the post-approval setting
Detailed Description
Time Perspective: this study does have a retrospective component involving a subset of patients
Eligibility Criteria
Inclusion
- For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
- Diagnosis of unresectable or metastatic melanoma
- Age of 18 years or older at time of entry into the study
- Patients who have initiated treatment for unresectable or metastatic melanoma at medical practice (e.g. community-based, office-based, hospital-based, academic setting)within 21 days before informed consent for this study OR in the case where treatment has not yet been initiated, documentation that the treatment strategy was determined before informed consent for this study, and treatment must be initiated within 28 days after informed consent
- Ipilimumab-treated patients must be receiving treatment for the indication(s) approved in their country of residence or where they are receiving treatment
Exclusion
- Current or pending participation in a clinical trial examining therapy for the treatment of any cancer (including unresectable or metastatic melanoma)
- Current use of therapy to treat a primary cancer other than melanoma
Key Trial Info
Start Date :
June 3 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 12 2019
Estimated Enrollment :
1411 Patients enrolled
Trial Details
Trial ID
NCT01511913
Start Date
June 3 2012
End Date
December 12 2019
Last Update
December 28 2021
Active Locations (186)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Gilbert, Arizona, United States, 85234
2
Local Institution
Hot Springs, Arkansas, United States, 71913
3
Local Institution
Encinitas, California, United States, 92024
4
Local Institution
La Jolla, California, United States, 92093